2021
DOI: 10.1016/j.atherosclerosis.2021.06.050
|View full text |Cite
|
Sign up to set email alerts
|

Soluble endoglin as a potential biomarker of nash development, participating in aggravation of nash-related changes in mouse liver

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles